Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Overview and Strategy
DVA logo

DaVita's 2023 Revenue Climbs 4.6% to $12.14B, U.S. Dialysis Operating Income Up 13.4%

DVA10-KFiling Date: 2/14/2024
DaVita Inc.
Description

What this story covers

DaVita's 2023 revenue rose 4.6% to $12.14 billion, driven by U.S. dialysis, international, and integrated kidney care growth. U.S. dialysis operating income increased 13.4% to $1.77 billion. Cash flow from operations surged to $2.06 billion, while debt and regulatory complexities remain key challenges.

Story snapshot

CompanyDaVita Inc.
TickerDVA
VariantStandard detailed
Duration27:27
Filing type10-K
PeriodAnnual 2023
IndustryHealthcare & Pharmaceuticals
Accession0000927066-24-000013

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in